CALIENT Announces New Strategy for Expanding Photonic Switching Market

The adaptive photonic switching company CALIENT Technologies announced the new CALIENT 3D MEMS Inside strategy for its photonic switching technology market expansion. The new strategy is also for creating partnerships with optical transport, packet switching, server, and router vendors.

The 3D MEMS (microelectromechanical systems) technology of CALIENT swaps the fiber-optic signals from one port to another with the help of silicon micro mirrors. The company has used its deep-silicon plasma etch process technology to produce the 3D MEMS mirrors. The FiberConnect 320X platform of CALIENT provides high-density photonic switch featuring 640 fiber terminations. The platform is being shipped to many Tier 1 service providers for eight years. The installed base of the product is 70,000 fiber terminations.

The aim of the CALIENT 3D MEMS Inside strategy is to manufacture a significantly small, advanced switch module. The company plans to further decrease the consumption of power to approximately 10% of the current switching systems. The target of the new products will be content provider, cloud computing, and data center applications.

The Chairman of CALIENT, Arjun Gupta, stated that the company has announced the strategy to utilize the various market trends that range from high bandwidth demand for video to the onset of CDC networks. Gupta also said that the company’s new photonic switches would satisfy the increasing demand for bandwidth cost-effectively, without a considerable increase in the consumption of power.

Source: http://www.calient.net/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.